LNSR Q3 2020 Earnings — LENSAR, Inc. Revenue & Financial Results | Market Cap Arena

LNSRLENSAR, Inc.

$141M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$7M-11.4% YoY

Gross Profit

$4M54.5% margin

Operating Income

-$5M-65.9% margin

Net Income

-$5M-66.7% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+41.6%

Cash Flow

Operating Cash Flow

-$55,000

Free Cash Flow

-$61,000

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$81M

Total Liabilities

$12M

Stockholders' Equity

$69M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$8M	-11.4%
Gross Profit	$4M	$3M	+19.0%
Operating Income	-$5M	-$5M	+11.7%
Net Income	-$5M	-$6M	+18.1%

Revenue Segments

Product

$5M87%

Service

$808,00013%

Geographic Segments

UNITED STATES

$3M51%

Asia Excluding South Korea

$1M24%

Europe

$761,00013%

KOREA, REPUBLIC OF

$642,00011%

Other Geographical Region

$87,0001%